Filana Therapeutics, Inc.
FLNA· Nasdaq
FLNAFilana Therapeutics, Inc.
Filed Apr 26, 2017 · 10-Q · 26 days after period end · 0001069530-17-000024
| Metric | Q1 2017 | Q1 2016 | Q1 2015 | Q1 2014 |
|---|---|---|---|---|
| Net Income | -$2.74M | -$5.80M | -$2.58M | -$3.45M |
| EPS Diluted | -$0.42 | -$0.13 | -$0.06 | -$0.08 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Filana Therapeutics, Inc. · CIK 1069530 · Engraved from SEC EDGAR
ended Mar 31, 2017 · filed Apr 26, 2017 · 26 d after period end
